Stockreport

New positive data from phase IIa trial in brain cancer patients

Kazia Therapeutics Limited - American Depositary Shares  (KZIA) 
US:NASDAQ Investor Relations: kaziatherapeutics.com
PDF SYDNEY, May 8, 2019 /PRNewswire/ -- With one month to go until World Brain Tumour Day on June 8, Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncol [Read more]